What's Going On With Neurocrine Biosciences Stock On Wednesday?
Reports of serious adverse events and deaths linked to Neurocrine's VYKAT XR for Prader-Willi syndrome prompt caution.
Neurocrine Biosciences has a medicine called VYKAT XR that some people got sick from or died after taking. When a company's medicine causes serious problems, people watch the stock carefully to see what happens next.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.